Clinical Trial Update: Repurposing of Dextromethorphan as an Adjunct Therapy in Patients With Major Depressive Disorder [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating repurposing dextromethorphan as an adjunct therapy for major depressive disorder has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• Dextromethorphan (dextromethorphan)

Snippet

Sponsor: All India Institute of Medical Sciences, Bhubaneswar | Conditions: Major Depressive Disorder | Phase 4 | Status: COMPLETED